Description: The tape has finally been broken on live reporting with International Financial Reporting Standard 17 (IFRS 17). The insurance industry across much of the world now pivots focus from implementation efforts to assessing disclosed impacts of the new global standard. During this session, the presenters will explore how equity positions are changing for companies after adopting IFRS 17, particularly given the recent interest rate environment.

Description: Go over how the actuarial processes have changed over the past 10+ years with the move to PBR, US GAAP LDTI, IFRS 17 and other emerging requirements.

Description: Internal modernization initiatives and external changes of the financial reporting regulations (e.g., LDTI, IFRS 17) increase the amount of validation activities for actuarial models. In addition, the use of predictive analytics in actuarial modeling requires a different set of validation skillsets/techniques in model validation. These internal and external forces call for a structured, streamlined and robust model validation practice.

Description: After the arduous journeys IFRS 17 filers underwent to implement the standard, it would only make sense for insurers to seek the best return on their investment post effective date of 1/1/2023. Many insurers are now embarking a new phase of the journey that involves wrapping up any unfinished business as they might have taken a minimum compliance route to finish implementation and thinking about the knock-on effects the new standard has on the way they carry out business and perform financial reporting.

Description: With Chapter 20 of the National Association of Insurance Commissioners Valuation Manual (VM-20), the expansion of accelerated underwriting programs and digital distribution, new accounting standards under GAAP long-duration targeted improvements (LDTI) and International Financial Reporting Standard (IFRS) 17, along with a changing interest rate environment, companies may be looking for efficient reinsurance solutions to help address these ever changing and varied challenges. Hear highlights on how reinsurance can be utilized to address the challenges associated with managing new business strain and product competitiveness, earnings and risk management, and capital allocation efficiency. At the conclusion of the session, you will understand the various challenges being faced by direct writing companies today and where reinsurance can be leveraged to improve the returns and competitiveness of product offerings, provide flexibility in capital and tax planning, as well as balancing risk appetite and underwriting profit retention.

Description: The Best Article in the Reinsurance News 2023 and News from the Reinsurance Section Council

Description: This article summarizes the second Simon Conference for young researchers in Actuarial Science, Risk Management, and Insurance, which took place at Michigan State University last November. The intent is to publicize the event and promote future participation in similar conferences of young researchers. The article will contribute to expanding the horizons of actuarial research performed by the academic community. Participation in the conference also gives professional development opportunity for practicing actuaries.

Description: The document is a Request for Proposals (RFP) for a research study on offshore life and annuity jurisdictions' reinsurance landscapes, commissioned by the Society of Actuaries Reinsurance Section. It outlines the background, purpose, research objectives, proposal requirements, selection process, submission details, and other related information.

Description: During the past few years, performance, cost, and risk trends for Medigap products have undergone substantial changes. Some of these trends could ease cost pressures on Medigap insurers, while others might increase them. Part 1 of this Issue Brief article discusses current changing trends and considerations around about how they are impacting Medigap.

Description: This is Part 2 of 2 on changes affecting Medigap insurers. It focuses on marketing and regulatory differences between Medigap and Medicare Advantage that affect the competitiveness of Medigap plans.